Q&A With Pers Sorensen From Copenhagen University: ECTRIMS Grows As Treatment Options For Multiple Sclerosis Expands

Name: Q&A With Pers Sorensen From Copenhagen University: ECTRIMS Grows As Treatment Options For Multiple Sclerosis Expands
Uploaded: 2015-10-11T15:28:00.000Z
Description: In 1992 the European Committee For Treatment And Research in Multiple Sclerosis met in Barcelona with 200 people in attendance. Twenty three years later the same conference was held in the same city with more than 9000 people in attendance and more than 1000 abstracts submitted.

October 11, 2015

Adam Hochron

Video

In 1992 the European Committee For Treatment And Research in Multiple Sclerosis met in Barcelona with 200 people in attendance. Twenty three years later the same conference was held in the same city with more than 9000 people in attendance and more than 1000 abstracts submitted.

In 1992 the European Committee For Treatment And Research in Multiple Sclerosis (ECTRIMS) met in Barcelona with 200 people in attendance. Twenty three years later the same conference was held in the same city with more than 9000 people in attendance and more than 1000 abstracts submitted.

Pers Sorenson, MD, DMSc, from Copenhagen University Hospital, who also serves as Secretary General for ECTRIMS discussed how the conference has grown during the most recent meeting in the Spanish city.

Treatment for the relapsing remitting form of multiple sclerosis has improved by leaps and bounds over the past few years and there are signs of progress for the primary progressive form as well. Even while improvements have been made there is still much more work to be done in the field.